CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hepatocytes
CD BioGlyco has rolled out a newly designed nucleic acid drug delivery system for siRNA- and mRNA-based therapeutics....
0 Comments 0 Shares